VergerC., LarpentL., DumontetN.Prognostic value of peritoneal equilibration curves in CAPD patients. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich and Associates, 1986: 88–93.
3.
BlakeP.G., SombolosK., IzattS., OreopoulosD.G.Low serum albumin predicts poor outcome in CAPD and is related to high peritoneal permeability (Abstract).J Am Soc Nephrol1990; 1: 383.
4.
BlakeP.G., SombolosK., IzattS., OreopoulosD.G.A highly permeable peritoneal membrane is an adverse risk factor in CAPD (Abstract).Clin Invest Med1991; 14: A127.
5.
LambE., BuhlerR., Cat tellW.R., DawneyA.Albumin transport during the peritoneal equilibration test: relationship to solute transport and effect of diabetes (Abstract).J Am Soc Nephrol1991; 2: 364.
6.
BlakeP.G., FlowerdewG., BlakeR.M., OreopoulosD.G.Serum albumin in patients on continuous ambulatory peritoneal dialysis -predictors and correlations with outcomes.J Am Soc Nephrol1993; 3: 1501–7.
7.
NolphK.D., MooreH.L., ProwantB.Continuous ambulatory peritoneal dialysis with a high flux membrane: a preliminary report.ASAIOJ1993; 39: M566–8.
8.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., AriszL.The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.Perit Dial Int1994; 14: 121–6.
9.
MalhotraD., TzamaloukasA.H., MurataG.H.Serum albumin in continuous peritoneal dialysis: its predictors and relationship to urea clearance.Kidney Int1996; 50: 243–9.
10.
ChurchillD.N., ThorpeK.E., NolphK.D., OreopoulosD.G., PagetD., KeshaviahP.R.for the Canada/USAPeritoneal Dialysis Study Group. CAPD patient and technique survivals are worse with increased membrane permeability (Abstract).Perit Dial Int1996; 16(Suppl 2): S21.
11.
LowrieE.G., LewH.L.Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities.Am J Kidney Dis1990; 15: 458–82.
HartyJ.C., BoultonH., VenningM.C., GokalR.Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients?Miner Electrolyte Metab1996; 22: 97–101.
14.
BergströmJ., FurstP., AlvestrandA.Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.Kidney Int1993; 44: 1048–57.
15.
AvramM.M., MittmanN., BonominiL., ChattopadhyayJ., FeinP.Markers for survival in dialysis: a seven year prospective study.Am J Kidney Dis1995; 26: 209–19.
16.
KaysenG.A., RathoreV., ShearerG.C., DepnerT.A.Mechanisms of hypoalbuminemia in hemodialysis patients.Kidney Int1995; 48:510–17.
17.
LameireN., VanholderR.C., Van LooA.Cardiovascular diseases in peritoneal dialysis patients: the size of the problem.Kidney Int1996; 50(Suppl 56): S28–36.
18.
RottembourgJ.Residual renal function and recovery of renal function in patients treated by CAPD.Kidney Int1993; 43(Suppl 40): S106–10.
19.
TzamaloukasA.H., SaddlerM.C., MurataG.H.Symptomatic fluid retention in patients on continuous peritoneal dialysis.J Am Soc Nephrol1995; 6: 198–206.
20.
PeersE., GokalR.Icodextrin: overview of clinical experience.Perit Dial Int1997; 17: 22–6.
